Krazati (adagrasib)

adagrasib · Mirati Therapeutics

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Krazati (adagrasib), covering 2025-02-11 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21) [Phase 2]